comparemela.com
Home
Live Updates
Sera Prognostics Shares More Than Double on Study Efficacy : comparemela.com
Sera Prognostics Shares More Than Double on Study Efficacy
By Denny Jacob Sera Prognostics shares more than doubled following news of study efficacy being met. The stock surged to $5.24 in early trading, vs....
Related Keywords
Denny Jacob ,
,
Data Safety Monitoring Board ,
Prematurity Risk Assessment Combined ,
Clinical Interventions ,
Improved Neonatal Outcomes ,
Article Normal ,
Biotechnology Services ,
Healthcare Life Sciences ,
Synd ,
Sera Prognostics ,
Sera ,
Us81749d1072 ,
Healthcare ,
Life Sciences ,
comparemela.com © 2020. All Rights Reserved.